A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors

Investigational New Drugs
Thierry DelaunoitCharles Erlichman

Abstract

CS-682 (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl)-N4-palmitoylcytosine) is a novel orally administered 2'-deoxycytidine-type antimetabolite, which has a wide spectrum of antitumor activity in human tumor xenograft models. We conducted a phase I study to define the toxicity, pharmacokinetics and antitumor activity of CS-682 in patients with advanced solid tumors. Forty patients were enrolled to receive escalating doses of CS-682. CS-682 was given orally, once daily three times a week (Monday, Wednesday and Friday), for four weeks consecutively, followed by a two-week rest period. Twenty-two men and 18 women, median age 63.5 (range 31 to 82) were treated. The most common tumor type was colorectal cancer with 15 patients. Others tumors occurring in 3 or more patients included prostate, breast and lung carcinomas. Sixty percent of the patients had received greater than 2 prior chemotherapy programs. Patients have been treated at each of the following dose levels (mg/m2/day): 1.5, 12, 20, 25, 30, 50, 67, 90, 120, 160 and 220. Non hematologic toxicities grade 3 [NCI Common Toxicity Criteria (version 2.0)] related to treatment included nausea in 2, vomiting in 1, anorexia and asthenia in 2, and dehydration in 1. Severe hemat...Continue Reading

Citations

Feb 2, 2012·Chemotherapy Research and Practice·Amy ZiembaGiuseppe Pizzorno
Nov 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hagop KantarjianWilliam Plunkett
May 23, 2014·Clinical Interventions in Aging·Ming Y Lim, Katarzyna Jamieson
Feb 15, 2012·Expert Opinion on Investigational Drugs·Xiaojun LiuWilliam Plunkett
Sep 29, 2011·Seminars in Oncology·Tapan M KadiaHagop Kantarjian
Apr 26, 2006·Journal of Physics. Condensed Matter : an Institute of Physics Journal·Jure DemsarAntoinette J Taylor
Jun 1, 2013·Nature Reviews. Drug Discovery·Lars Petter JordheimCharles Dumontet
May 3, 2014·Biological & Pharmaceutical Bulletin·Tohru ObataMotohiro Tanaka
Dec 21, 2007·Cancer Control : Journal of the Moffitt Cancer Center·Pete AndersonShaio Woo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.